Results 111 to 120 of about 691,238 (259)

Delta Elementary School P.T.A Officers

open access: yes, 1966
Left to Right: Genevieve Farnsworth-Vice President, Betty Jeffery-President, and Eldula Rawlinson-Secretary/Treasurer, 1966-1968, Delta ...

core  

The Effects of Compulsory Licensing: A Case Study of HIV Drugs

open access: yesHealth Economics, Volume 35, Issue 10, Page 1427-1434, October 2026.
ABSTRACT Compulsory licensing is a legal mechanism that allows governments the use of patented medicines without the owner's consent, subject to conditions and compensation, to meet public‐health needs. Despite its policy relevance and increasing use, empirical evidence on its market effects remains limited.
Nicolau Martin‐Bassols   +2 more
wiley   +1 more source

Prevalence and Genotyping of Hepatitis D Virus among HBs Ag Positive Patients Referred to Besat Clinic, Kerman during 2012-2013

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2016
Introduction: Hepatitis D virus (HDV) is a 35 nm in diameter agent that depends on hepatitis B surface antigen in order to proliferate and accumulate. Infection with delta agent can occur spontaneously with hepatitis B virus infection and it cause acute ...
Kh Barkhordari   +5 more
doaj  

Mucosal‐Associated Invariant T Cells in Health and Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao   +5 more
wiley   +1 more source

Developing RT-qPCR Kit for Detection and Quantification of Hepatitis D Virus Unique Genome

open access: yesCyprus Journal of Medical Sciences
BACKGROUND/AIMS: Hepatitis D virus (HDV) is a significant global health problem identified in the 1970s in Hepatitis B virus (HBV) positive patients.
Kıvanç Günhan   +9 more
doaj   +1 more source

Optimal Control‐Based RF Pulses Versus Classical Motion‐Encoding Strategies for In Vivo Hepatic MR Elastography Across Multiple Excitation Frequencies in Mice: Reproducibility Assessment

open access: yesNMR in Biomedicine, Volume 39, Issue 10, October 2026.
Optimal control (OC)–based motion encoding doubles SNR in vivo in murine hepatic MRE by eliminating motion‐encoding gradients and enabling shorter echo times. Quantitative liver stiffness measurements remain consistent with conventional MEG‐MRE across multiple excitation frequencies, supporting longitudinal studies and clinical translation ...
Tiffany Bakir‐Ageron   +5 more
wiley   +1 more source

Upcoming therapies for steatotic liver disease: Translating breakthroughs into clinical practice

open access: yesJournal of Internal Medicine, Volume 300, Issue 4, Page 440-460, October 2026.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and a leading cause of cirrhosis, hepatocellular carcinoma, and cardiometabolic morbidity. Often clinically silent until advanced fibrosis develops, management has largely relied on lifestyle interventions, with limited ...
Philip N. Newsome, Saima Ajaz
wiley   +1 more source

Evaluation of Signal/Cut-off Ratio by Anti-hepatitis Delta Virus Enzyme Immunoassay Method in the Diagnosis of Hepatitis Delta Virus Infection

open access: yes, 2019
Objectives: The hepatitis delta virus (HDV) is an enveloped, negative-sense, single-stranded RNA virus in the genus Deltavirus. In this study, it was aimed to evaluate the ratio of anti-HDV signal/cut-off (S/CO) in the diagnosis of HDV infection in ...
Alaçam, Sema   +5 more
core   +1 more source

Prognostic Value of Liver Stiffness in Advanced Chronic Liver Disease After Hepatitis C Virus Eradication

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background & Aim Sustained‐virological‐response (SVR) after direct‐acting‐antiviral (DAA) therapy improves outcomes in patients with HCV‐related compensated‐advanced‐chronic‐liver‐disease (cACLD). However, it remains unclear whether absolute post‐SVR LSM or LSM reduction better predicts prognosis after SVR.
Federica Cerini   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy